CVS Health CVS Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: CVS Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about CVS Health's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CVS Health's stock issuance proceeds?
- CVS Health (CVS) reported stock issuance proceeds of $103M in Q1 2026.
- How has CVS Health's stock issuance proceeds changed year-over-year?
- CVS Health's stock issuance proceeds decreased by 28.5% year-over-year, from $144M to $103M.
- What is the long-term trend for CVS Health's stock issuance proceeds?
- Over 4 years (2021 to 2025), CVS Health's stock issuance proceeds has grown at a -8.0% compound annual growth rate (CAGR), from $549M to $394M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.